Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging
Katrin Wittköpper, … , Thomas Eschenhagen, Ali El-Armouche
Katrin Wittköpper, … , Thomas Eschenhagen, Ali El-Armouche
Published January 11, 2010
Citation Information: J Clin Invest. 2010;120(2):617-626. https://doi.org/10.1172/JCI40545.
View: Text | PDF
Research Article Cardiology Article has an altmetric score of 1

Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging

  • Text
  • PDF
Abstract

Phosphatase inhibitor-1 (I-1) is a distal amplifier element of β-adrenergic signaling that functions by preventing dephosphorylation of downstream targets. I-1 is downregulated in human failing hearts, while overexpression of a constitutively active mutant form (I-1c) reverses contractile dysfunction in mouse failing hearts, suggesting that I-1c may be a candidate for gene therapy. We generated mice with conditional cardiomyocyte-restricted expression of I-1c (referred to herein as dTGI-1c mice) on an I-1–deficient background. Young adult dTGI-1c mice exhibited enhanced cardiac contractility but exaggerated contractile dysfunction and ventricular dilation upon catecholamine infusion. Telemetric ECG recordings revealed typical catecholamine-induced ventricular tachycardia and sudden death. Doxycycline feeding switched off expression of cardiomyocyte-restricted I-1c and reversed all abnormalities. Hearts from dTGI-1c mice showed hyperphosphorylation of phospholamban and the ryanodine receptor, and this was associated with an increased number of catecholamine-induced Ca2+ sparks in isolated myocytes. Aged dTGI-1c mice spontaneously developed a cardiomyopathic phenotype. These data were confirmed in a second independent transgenic mouse line, expressing a full-length I-1 mutant that could not be phosphorylated and thereby inactivated by PKC-α (I-1S67A). In conclusion, conditional expression of I-1c or I-1S67A enhanced steady-state phosphorylation of 2 key Ca2+-regulating sarcoplasmic reticulum enzymes. This was associated with increased contractile function in young animals but also with arrhythmias and cardiomyopathy after adrenergic stress and with aging. These data should be considered in the development of novel therapies for heart failure.

Authors

Katrin Wittköpper, Larissa Fabritz, Stefan Neef, Katharina R. Ort, Clemens Grefe, Bernhard Unsöld, Paulus Kirchhof, Lars S. Maier, Gerd Hasenfuss, Dobromir Dobrev, Thomas Eschenhagen, Ali El-Armouche

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 Total
Citations: 2 1 2 1 2 3 4 2 3 6 6 8 7 4 51
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (51)

Title and authors Publication Year
Metabolic Communication by SGLT2 Inhibition.
Billing AM, Kim YC, Gullaksen S, Schrage B, Raabe J, Hutzfeldt A, Demir F, Kovalenko E, Lassé M, Dugourd A, Fallegger R, Klampe B, Jaegers J, Li Q, Kravtsova O, Crespo-Masip M, Palermo A, Fenton RA, Hoxha E, Blankenberg S, Kirchhof P, Huber TB, Laugesen E, Zeller T, Chrysopoulou M, Saez-Rodriguez J, Magnussen C, Eschenhagen T, Staruschenko A, Siuzdak G, Poulsen PL, Schwab C, Cuello F, Vallon V, Rinschen MM
Circulation 2023
Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis
Ni H, Morotti S, Zhang X, Dobrev D, Grandi E
Cardiovascular Research 2023
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
A Saljic, J Heijman, D Dobrev
International journal of molecular sciences 2022
Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders
X Ai, J Yan, S Pogwizd
Cellular Signalling 2021
Molecular noise filtering in the β-adrenergic signaling network by phospholamban pentamers
Koch D, Alexandrovich A, Funk F, Kho AL, Schmitt JP, Gautel M
Cell Reports 2021
Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control
FS Rathjens, A Blenkle, LM Iyer, A Renger, F Syeda, C Noack, A Jungmann, M Dewenter, K Toischer, A El-Armouche, OJ Müller, L Fabritz, WH Zimmermann, LC Zelarayan, MP Zafeiriou
Cardiovascular Research 2020
Current Landscape of Heart Failure Gene Therapy
JM Kieserman, VD Myers, P Dubey, JY Cheung, AM Feldman
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2019
Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium
U Gergs, T Trapp, H Bushnaq, A Simm, RE Silber, J Neumann
Advances in Medicine 2019
Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression:
DY Chiang, KM Alsina, E Corradini, M Fitzpatrick, L Ni, SK Lahiri, J Reynolds, X Pan, L Scott, AJ Heck, XH Wehrens
Circulation 2018
AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload.
Schwab DM, Tilemann L, Bauer R, Heckmann M, Jungmann A, Wagner M, Burgis J, Vettel C, Katus HA, El-Armouche A, Müller OJ
Gene Therapy 2018
Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics.
Ferreira M, Beullens M, Bollen M, Van Eynde A
2018
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity
S Neef, J Heijman, K Otte, M Dewenter, AR Saadatmand, S Meyer-Roxlau, CL Antos, J Backs, D Dobrev, M Wagner, LS Maier, A El-Armouche
Naunyn-Schmiedeberg's Archives of Pharmacology 2017
Redox regulation of the actin cytoskeleton and its role in the vascular system
Q Xu, LP Huff, M Fujii, KK Griendling
Free radical biology & medicine 2017
Negative Adrenergic Feedback Specific to Phospholamban ∗
G Hasenfuss, SE Lehnart
JACC: Basic to Translational Science 2017
Profiling analysis of long non-coding RNAs in early postnatal mouse hearts
X Sun, Q Han, H Luo, X Pan, Y Ji, Y Yang, H Chen, F Wang, W Lai, X Guan, Q Zhang, Y Tang, J Chu, J Yu, W Shou, Y Deng, X Li
Scientific Reports 2017
The role of Epac in the heart
T Fujita, M Umemura, U Yokoyama, S Okumura, Y Ishikawa
Cellular and Molecular Life Sciences 2016
Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome
DY Chiang, AJ Heck, D Dobrev, XH Wehrens
Journal of Molecular and Cellular Cardiology 2016
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases
S Weber, S Meyer-Roxlau, M Wagner, D Dobrev, A El-Armouche
Frontiers in pharmacology 2015
Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias
K Haghighi, TJ Pritchard, GS Liu, VP Singh, P Bidwell, CK Lam, E Vafiadaki, P Das, J Ma, S Kunduri, D Sanoudou, S Florea, E Vanderbilt, HS Wang, J Rubinstein, RJ Hajjar, EG Kranias
Journal of Molecular and Cellular Cardiology 2015
Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractility: Up-regulation of micro-RNA765 in human failing hearts
WF Cai, GS Liu, CK Lam, S Florea, J Qian, W Zhao, T Pritchard, K Haghighi, D Lebeche, LJ Lu, J Deng, GC Fan, RJ Hajjar, EG Kranias
European Journal of Heart Failure 2015
Disruption of Epac1 decreases phosphorylation of phospholamban and protects the heart against stresses
Satoshi Okumura, Takayuki Fujita, Wenqian Cai, Meihua Jin, Iyuki Namekata, Yasumasa Mototani, Hui-Ling Jin, Yoshiki Ohnuki, Yayoi Tsuneoka, Reiko Kurotani, Kenji Suita, Yuko Kawakami, Shogo Hamaguchi, Takaya Abe, Hiroshi Kiyonari, Takashi Tsunematsu, Yunzhe Bai, Sayaka Suzuki, Yuko Hidaka, Masanari Umemura, Yasuhiro Ichikawa, Utako Yokoyama, Motohiko Sato, Fumio Ishikawa, Hiroko Izumi-Nakaseko, Satomi Adachi-Akahane, Hikaru Tanaka, Yoshihiro Ishikawa
Journal of Clinical Investigation 2014
Heart failure-specific changes in protein kinase signalling
K Lorenz, K Stathopoulou, E Schmid, P Eder, F Cuello
Pflügers Archiv - European Journal of Physiology 2014
Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes
ZH Slimane, I Bedioune, P Lechene, A Varin, F Lefebvre, P Mateo, V Domergue-Dupont, M Dewenter, W Richter, M Conti, A El-Armouche, J Zhang, R Fischmeister, G Vandecasteele
Cardiovascular Research 2014
Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease
D Dobrev, XH Wehrens
Circulation research 2014
p38α regulates SERCA2a function
L Kaikkonen, J Magga, VP Ronkainen, E Koivisto, Á Perjes, JK Chuprun, LE Vinge, T Kilpiö, J Aro, J Ulvila, T Alakoski, JA Bibb, I Szokodi, WJ Koch, H Ruskoaho, R Kerkelä
Journal of Molecular and Cellular Cardiology 2014
Development of phosphatase inhibitor-1 peptides acting as indirect activators of phosphatase 1.
Sotoud H, Borgmeyer U, Schulze C, El-Armouche A, Eschenhagen T
Naunyn-Schmiedeberg's Archives of Pharmacology 2014
Alterations in Ryanodine Receptors and Related Proteins in Heart Failure
S Ather, JL Respress, N Li, XH Wehrens
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model
C Weber, I Neacsu, B Krautz, P Schlegel, S Sauer, P Raake, J Ritterhoff, A Jungmann, AB Remppis, M Stangassinger, WJ Koch, HA Katus, OJ Müller, P Most, ST Pleger
Gene Therapy 2013
Active inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts
TJ Pritchard, Y Kawase, K Haghighi, A Anjak, W Cai, M Jiang, P Nicolaou, G Pylar, I Karakikes, K Rapti, J Rubinstein, RJ Hajjar, EG Kranias
PloS one 2013
Enhanced Ca²+ influx through cardiac L-type Ca²+ channels maintains the systolic Ca²+ transient in early cardiac atrophy induced by mechanical unloading
AP Schwoerer, S Neef, I Broichhausen, J Jacubeit, M Tiburcy, M Wagner, D Biermann, M Didié, C Vettel, LS Maier, WH Zimmermann, L Carrier, T Eschenhagen, T Volk, A El-Armouche, H Ehmke
Pflügers Archiv : European journal of physiology 2013
Age- and Gender-Related Changes in Ventricular Performance in Wild-Type FVB/N Mice as Evaluated by Conventional and Vector Velocity Echocardiography Imaging: A Retrospective Study
SE Koch, KJ Haworth, N Robbins, MA Smith, N Lather, A Anjak, M Jiang, P Varma, WK Jones, J Rubinstein
Ultrasound in Medicine & Biology 2013
Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice
P Kirchhof, E Marijon, L Fabritz, N Li, W Wang, T Wang, K Schulte, J Hanstein, JS Schulte, M Vogel, N Mougenot, S Laakmann, L Fortmueller, J Eckstein, S Verheule, S Kaese, A Staab, S Grote-Wessels, U Schotten, G Moubarak, XH Wehrens, W Schmitz, S Hatem, FU Müller
International Journal of Cardiology 2013
Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy
C Kho, A Lee, RJ Hajjar
Nature reviews. Cardiology 2012
Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging
S Florea, A Anjak, WF Cai, J Qian, E Vafiadaki, S Figueria, K Haghighi, J Rubinstein, J Lorenz, EG Kranias
Basic Research in Cardiology 2012
Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
EG Kranias, RJ Hajjar
Circulation research 2012
Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular Remodeling
Y Miyazaki, Y Ikeda, K Shiraishi, SN Fujimoto, H Aoyama, K Yoshimura, M Inui, M Hoshijima, H Kasahara, H Aoki, M Matsuzaki, P Rouet
PloS one 2012
Novel molecular targets for atrial fibrillation therapy
D Dobrev, L Carlsson, S Nattel
Nature Reviews Drug Discovery 2012
The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases
A Rietz, J Spiers
British Journal of Pharmacology 2012
Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice
S Laakmann, L Fortmüller, I Piccini, S Grote-Wessels, W Schmitz, G Breves, P Kirchhof, L Fabritz
Naunyn-Schmiedeberg's Archives of Pharmacology 2012
AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling
KM Fish, D Ladage, Y Kawase, I Karakikes, D Jeong, H Ly, K Ishikawa, L Hadri, L Tilemann, J Muller-Ehmsen, RJ Samulski, EG Kranias, RJ Hajjar
Circulation. Heart failure 2012
Impaired β-adrenergic responsiveness accentuates dysfunctional excitation–contraction coupling in an ovine model of tachypacing-induced heart failure
SJ Briston, JL Caldwell, MA Horn, JD Clarke, MA Richards, DJ Greensmith, HK Graham, MC Hall, DA Eisner, KM Dibb, AW Trafford
The Journal of Physiology 2011
The Inotropic Peptide βARKct Improves βAR Responsiveness in Normal and Failing Cardiomyocytes Through G βγ -Mediated L-Type Calcium Current Disinhibition
M Völkers, C Weidenhammer, N Herzog, G Qiu, K Spaich, F von Wegner, K Peppel, OJ Müller, S Schinkel, JE Rabinowitz, HJ Hippe, H Brinks, HA Katus, WJ Koch, AD Eckhart, O Friedrich, P Most
Circulation research 2011
In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
AM Shah, DL Mann
The Lancet 2011
Calcium Cycling Proteins and Their Association With Heart Failure
L Hadri, RJ Hajjar
Clinical Pharmacology & Therapeutics 2011
Age-related regulation of excitation–contraction coupling in rat heart
HB Kandilci, E Tuncay, EN Zeydanli, NN Sozmen, B Turan
Journal of Physiology and Biochemistry 2011
Systematic Analysis of Gene Expression Differences between Left and Right Atria in Different Mouse Strains and in Human Atrial Tissue
PC Kahr, I Piccini, L Fabritz, B Greber, H Schöler, HH Scheld, A Hoffmeier, NA Brown, P Kirchhof
PloS one 2011
The Small Heat Shock Protein 20 (Hsp20) Interacts with Protein Phosphatase-1 and Enhances Sarcoplasmic Reticulum Ca-Cycling
J Qian, E Vafiadaki, SM Florea, VP Singh, W Song, CK Lam, Y Wang, Q Yuan, TJ Pritchard, W Cai, K Haghighi, P Rodriguez, HS Wang, D Sanoudou, GC Fan, EG Kranias
Circulation research 2011
Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?
Thomas Eschenhagen
Journal of Clinical Investigation 2010
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications
D Dobrev, N Voigt, XH Wehrens
Cardiovascular Research 2010
Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress?
K Wittköpper, T Eschenhagen, A El-Armouche
Basic Research in Cardiology 2010
Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis
G Chen, X Zhou, S Florea, J Qian, W Cai, Z Zhang, GC Fan, J Lorenz, RJ Hajjar, EG Kranias
Basic Research in Cardiology 2010

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
58 readers on Mendeley
See more details